Hugh Logan Ellis1, Bettina Wan1, Michael Yeung1, Arshad Rather1, Imran Mannan1, Catherine Bond1, Catherine Harvey1, Nadia Raja1, Peter Dutey-Magni1, Kenneth Rockwood1, Daniel Davis1, Samuel D Searle2. 1. University College London Hospitals NHS Foundation Trust (Logan Ellis, Wan, Yeung, Rather, Mannan, Bond, Harvey, Raja, Davis); Institute of Health Informatics (Dutey-Magni), UCL; MRC Unit for Lifelong Health and Ageing at UCL (Davis, Searle), London, UK; Division of Geriatric Medicine, Department of Medicine (Rockwood, Searle), Dalhousie University, Halifax, NS. 2. University College London Hospitals NHS Foundation Trust (Logan Ellis, Wan, Yeung, Rather, Mannan, Bond, Harvey, Raja, Davis); Institute of Health Informatics (Dutey-Magni), UCL; MRC Unit for Lifelong Health and Ageing at UCL (Davis, Searle), London, UK; Division of Geriatric Medicine, Department of Medicine (Rockwood, Searle), Dalhousie University, Halifax, NS ssearle@dal.ca.
Abstract
BACKGROUND: Acutely ill and frail older adults have complex social and health care needs. It is important to understand how this complexity affects acute outcomes for admission to hospital. We validated a frailty index using routine admission laboratory tests with outcomes after patients were admitted to hospital. METHODS: In a prospective cohort of older adults admitted to a large tertiary hospital in the United Kingdom, we created a frailty index from routine admission laboratory investigations (FI-Laboratory) linked to data comprising hospital outcomes. We evaluated the association between the FI-Laboratory and total days spent in hospital, discharge to a higher level of care, readmission and mortality. RESULTS: Of 2552 admissions among 1750 older adults, we were able to generate FI-Laboratory values for 2254 admissions (88.3% of the cohort). More than half of admitted patients were women (55.3%) and the mean age was 84.6 (SD 14.0) years. We found that the FI-Laboratory correlated weakly with the Clinical Frailty Scale (CFS; r 2 = 0.09). An increase in the CFS and the equivalent of 3 additional abnormal laboratory test results in the FI-Laboratory, respectively, were associated with an increased proportion of inpatient days (rate ratios [RRs] 1.43, 95% confidence interval [CI] 1.35-1.52; and 1.47, 95% CI 1.41-1.54), discharge to a higher level of care (odd ratios [ORs] 1.39, 95% CI 1.27-1.52; and 1.30, 95% CI 1.16-1.47) and increased readmission rate (hazard ratios [HRs] 1.26, 95% CI 1.17-1.37; and 1.18, 95% CI 1.11-1.26). Increases in the CFS and FI-Laboratory were associated with increased mortality HRs of 1.39 (95% CI 1.28-1.51) and 1.45 (95% CI 1.37-1.54), respectively. INTERPRETATION: We determined that FI-Laboratory, distinct from baseline frailty, could be used to predict risk of many adverse outcomes. The score is therefore a useful way to quantify the degree of acute illness in frail older adults.
BACKGROUND: Acutely ill and frail older adults have complex social and health care needs. It is important to understand how this complexity affects acute outcomes for admission to hospital. We validated a frailty index using routine admission laboratory tests with outcomes after patients were admitted to hospital. METHODS: In a prospective cohort of older adults admitted to a large tertiary hospital in the United Kingdom, we created a frailty index from routine admission laboratory investigations (FI-Laboratory) linked to data comprising hospital outcomes. We evaluated the association between the FI-Laboratory and total days spent in hospital, discharge to a higher level of care, readmission and mortality. RESULTS: Of 2552 admissions among 1750 older adults, we were able to generate FI-Laboratory values for 2254 admissions (88.3% of the cohort). More than half of admitted patients were women (55.3%) and the mean age was 84.6 (SD 14.0) years. We found that the FI-Laboratory correlated weakly with the Clinical Frailty Scale (CFS; r 2 = 0.09). An increase in the CFS and the equivalent of 3 additional abnormal laboratory test results in the FI-Laboratory, respectively, were associated with an increased proportion of inpatient days (rate ratios [RRs] 1.43, 95% confidence interval [CI] 1.35-1.52; and 1.47, 95% CI 1.41-1.54), discharge to a higher level of care (odd ratios [ORs] 1.39, 95% CI 1.27-1.52; and 1.30, 95% CI 1.16-1.47) and increased readmission rate (hazard ratios [HRs] 1.26, 95% CI 1.17-1.37; and 1.18, 95% CI 1.11-1.26). Increases in the CFS and FI-Laboratory were associated with increased mortality HRs of 1.39 (95% CI 1.28-1.51) and 1.45 (95% CI 1.37-1.54), respectively. INTERPRETATION: We determined that FI-Laboratory, distinct from baseline frailty, could be used to predict risk of many adverse outcomes. The score is therefore a useful way to quantify the degree of acute illness in frail older adults.
Authors: Alice E Kane; Kaitlyn M Keller; Stefan Heinze-Milne; Scott A Grandy; Susan E Howlett Journal: J Gerontol A Biol Sci Med Sci Date: 2019-02-15 Impact factor: 6.053
Authors: Kenneth Rockwood; Xiaowei Song; Chris MacKnight; Howard Bergman; David B Hogan; Ian McDowell; Arnold Mitnitski Journal: CMAJ Date: 2005-08-30 Impact factor: 8.262
Authors: Ghalib A Bello; Roberto G Lucchini; Susan L Teitelbaum; Moshe Shapiro; Michael A Crane; Andrew C Todd Journal: Curr Gerontol Geriatr Res Date: 2018-02-26
Authors: Jacqueline M McMillan; Michael John Gill; Christopher Power; Esther Fujiwara; David B Hogan; Leah H Rubin Journal: AIDS Patient Care STDS Date: 2020-07 Impact factor: 5.078
Authors: Jacob A Martin; Andrew Crane-Droesch; Folasade C Lapite; Joseph C Puhl; Tyler E Kmiec; Jasmine A Silvestri; Lyle H Ungar; Bruce P Kinosian; Blanca E Himes; Rebecca A Hubbard; Joshua M Diamond; Vivek Ahya; Michael W Sims; Scott D Halpern; Gary E Weissman Journal: J Am Med Inform Assoc Date: 2021-12-28 Impact factor: 4.497
Authors: Rafael Bielza; Cristina Balaguer; Francisco Zambrana; Estefanía Arias; Israel J Thuissard; Ana Lung; Carlos Oñoro; Patricia Pérez; Cristina Andreu-Vázquez; Marta Neira; Noemi Anguita; Carmen Sáez; Eva María Fernández de la Puente Journal: Eur Geriatr Med Date: 2022-04-23 Impact factor: 3.269
Authors: Rafael Bielza; Juan Sanz; Francisco Zambrana; Estefanía Arias; Eduardo Malmierca; Laura Portillo; Israel J Thuissard; Ana Lung; Marta Neira; María Moral; Cristina Andreu-Vázquez; Ana Esteban; Marcela Irma Ramírez; Laura González; Guillermo Carretero; Ricardo Vicente Moreno; Pilar Martínez; Javier López; Mar Esteban-Ortega; Isabel García; María Antonia Vaquero; Ana Linares; Ana Gómez-Santana; Jorge Gómez Cerezo Journal: J Am Med Dir Assoc Date: 2020-12-11 Impact factor: 4.669
Authors: Robert De Smet; Bea Mellaerts; Hannelore Vandewinckele; Peter Lybeert; Eric Frans; Sara Ombelet; Wim Lemahieu; Rolf Symons; Erwin Ho; Johan Frans; Annick Smismans; Michaël R Laurent Journal: J Am Med Dir Assoc Date: 2020-06-09 Impact factor: 4.669